Using a patient's own bone marrow cells can help an ailing heart

November 13, 2001

ANAHEIM, Calif., Nov. 12 - In the first study of its kind, researchers have used a person's own bone marrow cells to improve blood flow in otherwise untreatable coronary arteries, according to research presented today at the American Heart Association's Scientific Sessions 2001 conference.

Kimikazu Hamano, M.D., and his colleagues reported results from an ongoing clinical trial in which five patients received injections of their own bone marrow cells into oxygen-starved areas of their hearts. Three of these patients later had increased blood flow in these areas. "We found this new treatment to be safe, and we believe it could be an alternative treatment for heart patients who cannot be helped by coronary artery bypass surgery or balloon angioplasty," says Hamano, a lecturer at the Yamaguchi University School of Medicine in Ube, Japan. Bypass surgery and angioplasty can improve blood flow to the hearts of many patients whose coronary arteries are clogged and narrowed by fatty deposits. But others cannot be helped at all or portions of their heart cannot benefit from the procedures. This is often because their heart disease is too widespread.

Injecting adult stem cells from the patient's own bone marrow is easy, relatively inexpensive and appears to have no side effects, Hamano says. Stem cells are basic building block cells that can grow into specialized cells in the body, such as heart cells, nerve cells and organ cells. The Japanese team began their human trial after a series of animal experiments. The first patient was injected with his own bone marrow cells in November 1999.

"We have good results from these experiments in animal studies," Hamano says. "The aim of the current trial is to confirm the safety and efficacy of this treatment in humans." He and his colleagues selected their study participants from among patients who were scheduled to undergo bypass surgery. Their five patients had an average age of 66 and all suffered severe and debilitating chest pain (angina). They were chosen because areas of their heart muscle could not receive any benefit from the bypass surgery.

As surgeons began bypass surgery on each participant, the researchers withdrew bone marrow from the patient's hip bone. From this harvested marrow, they prepared a mixture rich in mononuclear cells, which includes immature cells such as stem cells and the precursor cells of the endothelial cells that line the inner walls of blood vessels.

Depending on the size of the area of heart muscle treated, the patients received between five and 22 injections of cells into the heart muscle, administered 1 centimeter (0.39 inch) apart. The patients were examined one month after their injections/operations using a nuclear medicine test called cardiac scintigraphy. Scintigraphy measures coronary perfusion, which is the amount of blood flowing to the heart. All of the patients have been followed for at least one year.

Three of the five patients showed marked improvement in blood flow to the parts of their heart treated with bone marrow. Their severe chest pain also had disappeared. The other two patients, however, had no change in blood flow compared to preoperative tests. Chest X-rays, blood tests, electrocardiography, and ultrasound studies did not reveal any detrimental changes in any patients.

Despite evidence in three patients of increased blood flow in the treated areas, "It was difficult to clearly identify new vessels formed by this treatment on postoperative angiograms," Hamano says. Angiography uses a combination of X-rays and a dye injected into the heart's arteries to visualize the organ's blood vessels. However, this failure to detect new vessels did not surprise the researchers.

"From our experimental data, the new vessels formed as the result of bone marrow cell injections were only 30 to 60 micrometers (about 0.00117 to 0.00234 inch) in diameter," Hamano explains. "The detection level of blood vessels by angiography is more than 200 micrometers. Therefore, it is understandable that we could not see the new vessels."

The important finding, he says, is the evidence of greater blood flow to the heart muscle. Hamano and his colleagues have now treated a sixth patient as part of their continuing study. Co-authors are: Masahiko Nishida, M.D.; Ken Hirata, M.D.; Akihito Mikamo, M.D., Ph.D.; Tao-Sheng Li, M.D., Ph.D.; Kensuke Esato, M.D., Ph.D.; Masahiko Harada, M.D., Ph.D.; and Toshiro Miura, M.D., Ph.D.

NR01 - 1367 (SS01/Hamano)
-end-
FOR RELEASE:
10 a.m. PST, Tuesday
November 13, 2001
(Note: This will be included in a news conference on Tuesday)

CONTACT:
For information Nov. 10-14,
contact Carole Bullock or Maggie Francis at the Hilton Anaheim Hotel
(714) 251-5801

Abstract 335 (Poster)

American Heart Association

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.